| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6185277 | Gynecologic Oncology | 2013 | 6 Pages |
Abstract
AKT signaling is an important determinant of OVCA response to chemotherapy and overall patient survival. Our data provide insight into the molecular basis to perifosine activity and identifies pathways associated with perifosine sensitivity and patient clinical outcome.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Entidhar Al Sawah, Xin Chen, Douglas C. Marchion, Yin Xiong, Ingrid J. Ramirez, Forough Abbasi, Nadim Bou Zgheib, Hye Sook Chon, Robert M. Wenham, Sachin M. Apte, Patricia L. Judson, Johnathan M. Lancaster,